The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

Cardinal Health said on Tuesday it will buy healthcare management firm Solaris Health for $1.9 billion in cash, as the drug ...

BigBear.ai tumbles as the AI company reports disappointing earnings and guidance, while Hanesbrands jumps following a report ...

Recent acquisitions helped to slightly lift the healthcare-products distributor’s profit and revenue, as the company faces ...

Cardinal Health Inc. ended its nine-year string of record revenue with a 2% decline in fiscal 2025. Here's why that was a ...

Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and ...

Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results ...

Guidance for fiscal 2026 EPS was raised to $9.30-$9.50, an increase of $0.20 from previous guidance, supported by both liability classification changes and stronger business performance. Pharma ...

Dublin, Ohio-based Cardinal Health raised its fiscal 2026 adjusted earnings per share forecast to $9.30 to $9.50, ahead of ...

Looking forward, Cardinal Health now expects adjusted earnings of $9.30 to $9.50 a share in its fiscal 2026, up from a prior outlook of $9.10 to $9.30 a share. Analysts were looking for adjusted ...